These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8159110)

  • 1. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
    Pugliese G; Tilton RG; Speedy A; Oates PJ; Williamson JR
    Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
    Pugliese G; Tilton RG; Speedy A; Chang K; Province MA; Kilo C; Williamson JR
    Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
    J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
    Mauer SM; Steffes MW; Azar S; Brown DM
    Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Coleman BD; Williamson JR; Tilton RG
    Diabetes; 1991 May; 40(5):574-82. PubMed ID: 1902427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes-induced increases in vascular permeability and changes in granulation tissue levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinil.
    Williamson JR; Chang K; Rowold E; Marvel J; Tomlinson M; Sherman WR; Ackermann KE; Kilo C
    Metabolism; 1986 Apr; 35(4 Suppl 1):41-5. PubMed ID: 3959907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of aldose reductase inhibition and dietary protein restriction on renal function in experimental diabetes mellitus.
    McCormack AJ; Hak LJ; Finn WF
    Ren Fail; 1991; 13(4):267-74. PubMed ID: 1780495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of proteinuria by sorbinil, an aldose reductase inhibitor in spontaneously diabetic (BB) rats.
    Beyer-Mears A; Murray FT; Del Val M; Cruz E; Sciadini M
    Pharmacology; 1988; 36(2):112-20. PubMed ID: 3127836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
    Willars GB; Calcutt NA; Compton AM; Tomlinson DR; Keen P
    J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil.
    Sutera SP; Chang K; Marvel J; Williamson JR
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H945-50. PubMed ID: 1415621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
    Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
    Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
    Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
    Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol.
    Pugliese G; Tilton RG; Speedy A; Santarelli E; Eades DM; Province MA; Kilo C; Sherman WR; Williamson JR
    Diabetes; 1990 Mar; 39(3):312-22. PubMed ID: 2307293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.
    Körner A; Celsi G; Eklöf AC; Linné T; Persson B; Aperia A
    Diabetologia; 1992 May; 35(5):414-8. PubMed ID: 1521721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sorbinil treatment in rats with chronic streptozotocin-diabetes; changes in lens and in substance P and catecholamines in the iris.
    Tomlinson DR; Willars GB; Calcutt NA; Compton AM; Macdonald IA; Clarke HE; Keen P
    Curr Eye Res; 1989 Apr; 8(4):357-63. PubMed ID: 2470551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
    Tilton RG; Chang K; Hasan KS; Smith SR; Petrash JM; Misko TP; Moore WM; Currie MG; Corbett JA; McDaniel ML
    Diabetes; 1993 Feb; 42(2):221-32. PubMed ID: 7678825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration.
    Williamson JR; Chang K; Tilton RG; Prater C; Jeffrey JR; Weigel C; Sherman WR; Eades DM; Kilo C
    Diabetes; 1987 Jul; 36(7):813-21. PubMed ID: 3108058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.